Multiple Manufacturers

GADAVIST

Manufacturer:

Multiple Manufacturers

Gadavist HCPCS:

A9585

HCPCS Code Descriptor:

Injection, gadobutrol, 0.1 ml

Category:

A Code

Gadavist NDCs:

50419-0325-15, 50419-0325-19, 50419-0325-13, 50419-0325-14, 50419-0325-18, 65219-0281-15, 50419-0325-12, 50419-0325-11, 65219-0281-10, 65219-0281-07, 50419-0325-29, 50419-0325-28, 50419-0325-27, 50419-0325-37, 65219-0281-02

Primary Type:

Imaging/Radiopharmaceutical

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Gadavist:

GADAVIST is an Imaging/Radiopharmaceutical drug manufactured by Bayer and administered via the Intravenous route of administration. The A Code: A9585 is aligned to the drug GADAVIST.

Gadavist is a contract agent used before patients undergo MRIs, or magnetic resonance imaging. Doctors may inject Gadavist into a patient before they undergo an MRI to help make the imaging clearer and easier to read. Gadavist works by helping to detect and visualize areas of the body with disruptions to the blood brain barrier and/or abnormal vascularity.

ACCESS PRICING AND MORE BY REGISTERING

A9585 Added Date:

January 1, 2012

A9585 Effective Date:

January 1, 2012

A9585 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Gadavist billing and coding information.
Our team did not identify a source for Gadavist patient assistance information. Please reach out to our team if you feel that this is a mistake.
GADAVIST prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for GADAVIST. Please check back in a few weeks.